NYSE:ABC

AmerisourceBergen Stock Forecast, Price & News

$121.31
+1.47 (+1.23 %)
(As of 07/23/2021 12:00 AM ET)
Add
Compare
Today's Range
$119.91
$122.56
50-Day Range
$112.60
$121.31
52-Week Range
$92.00
$125.86
Volume956,685 shs
Average Volume953,799 shs
Market Capitalization$24.92 billion
P/E RatioN/A
Dividend Yield1.47%
Beta0.55
30 days | 90 days | 365 days | Advanced Chart
Receive ABC News and Ratings via Email

Sign-up to receive the latest news and ratings for AmerisourceBergen and its competitors with MarketBeat's FREE daily newsletter.


AmerisourceBergen logo

About AmerisourceBergen

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; offers specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in both the companion animal and production animal markets, as well as provides demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

1.51 out of 5 stars

Medical Sector

589th out of 2,215 stocks

Drugs, Proprietaries, & Sundries Industry

6th out of 16 stocks

Analyst Opinion: 1.3Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 0.8Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











AmerisourceBergen (NYSE:ABC) Frequently Asked Questions

Is AmerisourceBergen a buy right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last twelve months. There are currently 4 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AmerisourceBergen stock.
View analyst ratings for AmerisourceBergen
or view top-rated stocks.

What stocks does MarketBeat like better than AmerisourceBergen?

Wall Street analysts have given AmerisourceBergen a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AmerisourceBergen wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is AmerisourceBergen's next earnings date?

AmerisourceBergen is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for AmerisourceBergen
.

How can I listen to AmerisourceBergen's earnings call?

AmerisourceBergen will be holding an earnings conference call on Wednesday, August 4th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "10157948".

How were AmerisourceBergen's earnings last quarter?

AmerisourceBergen Co. (NYSE:ABC) posted its quarterly earnings data on Tuesday, May, 4th. The company reported $2.53 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $2.48 by $0.05. The business earned $49.15 billion during the quarter, compared to analysts' expectations of $50.06 billion. AmerisourceBergen had a positive trailing twelve-month return on equity of 277.60% and a negative net margin of 1.91%. The company's revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.40 EPS.
View AmerisourceBergen's earnings history
.

How has AmerisourceBergen's stock been impacted by COVID-19?

AmerisourceBergen's stock was trading at $84.96 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ABC stock has increased by 42.8% and is now trading at $121.31.
View which stocks have been most impacted by COVID-19
.

How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?

AmerisourceBergen declared a quarterly dividend on Wednesday, May 5th. Shareholders of record on Monday, May 17th will be given a dividend of $0.44 per share on Tuesday, June 1st. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.45%. The ex-dividend date of this dividend is Friday, May 14th.
View AmerisourceBergen's dividend history
.

Is AmerisourceBergen a good dividend stock?

AmerisourceBergen pays an annual dividend of $1.76 per share and currently has a dividend yield of 1.47%. AmerisourceBergen does not yet have a strong track record of dividend growth. The dividend payout ratio of AmerisourceBergen is 22.28%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, AmerisourceBergen will have a dividend payout ratio of 17.22% next year. This indicates that AmerisourceBergen will be able to sustain or increase its dividend.
View AmerisourceBergen's dividend history.

What guidance has AmerisourceBergen issued on next quarter's earnings?

AmerisourceBergen updated its FY 2021 earnings guidance on Tuesday, June, 29th. The company provided earnings per share guidance of $8.900-$9.100 for the period, compared to the Thomson Reuters consensus estimate of $8.540. The company issued revenue guidance of $210 B-, compared to the consensus revenue estimate of $204.74 billion.

What price target have analysts set for ABC?

11 analysts have issued twelve-month price targets for AmerisourceBergen's shares. Their forecasts range from $112.00 to $150.00. On average, they expect AmerisourceBergen's stock price to reach $128.25 in the next year. This suggests a possible upside of 5.7% from the stock's current price.
View analysts' price targets for AmerisourceBergen
or view top-rated stocks among Wall Street analysts.

Who are AmerisourceBergen's key executives?

AmerisourceBergen's management team includes the following people:
  • Mr. Steven H. Collis, Chairman, Pres & CEO (Age 60, Pay $4.55M)
  • Mr. James F. Cleary Jr., Exec. VP & CFO (Age 58, Pay $1.78M)
  • Ms. Gina K. Clark, Exec. VP and Chief Communications & Admin. Officer (Age 64, Pay $1.46M)
  • Mr. John G. Chou, Exec. VP & Chief Legal Officer (Age 65, Pay $1.75M)
  • Dr. Robert P. Mauch PharmD, Ph.D., Exec. VP & Group Pres (Age 54, Pay $1.81M)
  • Mr. Lazarus Krikorian, Sr. VP, Chief Accounting Officer & Corp. Controller (Age 56)
  • Bennett S. Murphy, Sr. VP of Investor Relations
  • Ms. Kathy H. Gaddes, Exec. VP & Chief Compliance Officer (Age 58)
  • Ms. Silvana Battaglia, Exec. VP & Chief HR Officer (Age 54)
  • Ms. Leslie E. Donato, Exec. VP & Chief Strategy Officer (Age 52)

What is Steve Collis' approval rating as AmerisourceBergen's CEO?

447 employees have rated AmerisourceBergen CEO Steve Collis on Glassdoor.com. Steve Collis has an approval rating of 83% among AmerisourceBergen's employees.

Who are some of AmerisourceBergen's key competitors?

What other stocks do shareholders of AmerisourceBergen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AmerisourceBergen investors own include NVIDIA (NVDA), Intel (INTC), AbbVie (ABBV), The Walt Disney (DIS), CVS Health (CVS), Johnson & Johnson (JNJ), AT&T (T), JPMorgan Chase & Co. (JPM), The Home Depot (HD) and Pfizer (PFE).

What is AmerisourceBergen's stock symbol?

AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

Who are AmerisourceBergen's major shareholders?

AmerisourceBergen's stock is owned by a variety of institutional and retail investors. Top institutional investors include Cypress Capital Group (0.02%), State of Alaska Department of Revenue (0.01%), Selway Asset Management (0.01%), IFM Investors Pty Ltd (0.01%), Oregon Public Employees Retirement Fund (0.01%) and Archford Capital Strategies LLC (0.01%). Company insiders that own AmerisourceBergen stock include Dermot Mark Durcan, Gina Clark, Henry Wadsworth Mcgee III, Jane E Md Henney, John G Chou, Kathleen W Hyle, Kathy H Gaddes, Lazarus Krikorian, Robert P Mauch and Steven H Collis.
View institutional ownership trends for AmerisourceBergen
.

Which institutional investors are selling AmerisourceBergen stock?

ABC stock was sold by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, Raymond James Trust N.A., Fulton Bank N.A., Cypress Capital Group, and State of Alaska Department of Revenue. Company insiders that have sold AmerisourceBergen company stock in the last year include Gina Clark, Henry Wadsworth Mcgee III, John G Chou, Robert P Mauch, and Steven H Collis.
View insider buying and selling activity for AmerisourceBergen
or view top insider-selling stocks.

Which institutional investors are buying AmerisourceBergen stock?

ABC stock was purchased by a variety of institutional investors in the last quarter, including Selway Asset Management, IFM Investors Pty Ltd, Pflug Koory LLC, Archford Capital Strategies LLC, and New Mexico Educational Retirement Board.
View insider buying and selling activity for AmerisourceBergen
or or view top insider-buying stocks.

How do I buy shares of AmerisourceBergen?

Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AmerisourceBergen's stock price today?

One share of ABC stock can currently be purchased for approximately $121.31.

How much money does AmerisourceBergen make?

AmerisourceBergen has a market capitalization of $24.92 billion and generates $189.89 billion in revenue each year. The company earns $-3,408,720,000.00 in net income (profit) each year or $7.90 on an earnings per share basis.

How many employees does AmerisourceBergen have?

AmerisourceBergen employs 22,000 workers across the globe.

Does AmerisourceBergen have any subsidiaries?

The following companies are subsidiares of AmerisourceBergen: ASD Specialty Healthcare LLC, Access M.D., Alliance Healthcare, Amerisource Receivables Financial Corporation, AmerisourceBergen Drug Corporation, AmerisourceBergen Global Holdings GmbH, AmerisourceBergen Global Manufacturer Services GmbH, AmerisourceBergen Group AG, AmerisourceBergen International Holdings Inc., AmerisourceBergen Luxembourg S.a.r.L., AmerisourceBergen Services Corporation, AmerisourceBergen Specialty Group LLC, Anderson Packaging, AutoMed Technologies, BPL Group LLC, BPLH Ireland Unlimited Company, Bellco Health, Brecon Pharmaceuticals, Bridge Medical Inc, CD Smith Healthcare, H. D. Smith, IgG America, International Oncology Network Solutions Inc., IntrinsiQ, Lash Group, MWI Veterinary Supply, MWI Veterinary Supply Co., MWI Veterinary Supply Inc., Network for Medical Communications & Research, PharMEDium Healthcare, Pharmacy Healthcare Solutions, Premier Source, St. Francis Group, Trent Drug, US Bioservices, World Courier, World Courier Group S.à r.l., and Xcenda.

When was AmerisourceBergen founded?

AmerisourceBergen was founded in 2001.

What is AmerisourceBergen's official website?

The official website for AmerisourceBergen is www.amerisourcebergen.com.

Where are AmerisourceBergen's headquarters?

AmerisourceBergen is headquartered at 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087.

How can I contact AmerisourceBergen?

AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at 610-727-7000 or via email at [email protected]


This page was last updated on 7/24/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.